Presynaptic action of trifluoperazine at the frog neuromuscular junction
- 14 Downloads
Treatment of frog neuromuscular preparations bathed in basic frog saline (1.8 mM Ca2+) with trifluoperazine (25 μM) caused an increase in MEPP frequency in 6 out of 10 preparations tested. The mean normalised MEPP frequency after 15 min of treatment was approximately 1.5. 10 μM trifluoperazine had a similar effect. In salines containing low concentrations of Ca2+ (50 μM Ca2+, 2 mM Mg2+ or 0 Ca2+, 1 mM EGTA) the stimulatory action of trifluoperazine was more marked and occurred in a higher proportion of the preparations tested (11 out of 14).
When evoked release of transmitter was reduced to very low levels by Mg2+-containing salines treatment with trifluoperazine (2.5–25 μM) caused an increase in quantal content of 20–60%.
Depolarisation of preparations bathed in standard frog saline by increasing [K+]0 to 10 mM resulted in a 10-fold increase in MEPP frequency. This response was inhibited by about 25% in 10 μM trifluoperazine and by about 45% in 25 μM trifluoperazine.
Pre-treatment of preparations with trifluoperazine (25 μM) caused a marked reduction in the response of MEPP frequency to tetanic stimulation (50 Hz) both in the presence of an inward electrochemical gradient for Ca2+ (50 μM Ca2+, 2 mM Mg2+) and in a Ca2+-free saline (0 Ca2+, 1 mM EGTA). The effects of trifluoperazine on tetanic enhancement of MEPP frequency are compared to those of other agents and it is shown that the results are inconsistent with an effect of the drug on Ca2+-fluxes at the plasma membrane.
It is concluded that trifluoperazine has both stimulatory and inhibitory effects on transmitter release at the frog neuromuscular junction and that the inhibitory effect is probably due to inhibition of excitation-secretion coupling at a point subsequent to Ca2+ mobilization.
Key wordsCalmodulin Excitation-secretion coupling MEPP Neuromuscular junction Trifluoperazine
Unable to display preview. Download preview PDF.
- Alobaidi T, Naccache PH, Sha'afi RI (1981) Calmodulin antagonists modulate rabbit neutrophil degranulation, aggregation and stimulated oxygen consumption. Biochim Biophys Acta 675:316–321Google Scholar
- Argov Z, Yaari Y (1979) The action of chlorpromazine at an isolated cholinergic synapse. Brain Res 164:227–236Google Scholar
- Cheng K-C, Lambert JJ, Henderson EG, Smilowitz H, Epstein PM (1981) Postsynaptic inhibition of neuromuscular transmission by trifluoperazine. J Pharmacol Exp Ther 217:44–50Google Scholar
- Cheung WY (1980) Calmodulin plays a pivotal role in cellular regulation. Science 207:19–27Google Scholar
- Crawford AC (1974) The dependence of evoked transmitter release on external calcium ions at very low mean quantal contents. J Physiol 240:255–278Google Scholar
- DeLorenzo RJ (1981) The calmodulin hypothesis of neurotransmission. Cell Calcium 2:365–385Google Scholar
- DeLorenzo RJ (1982) Calmodulin in neurotransmitter release and synaptic function. Fed Proc 41:2265–2272Google Scholar
- DeLorenzo RJ, Freedman SD, Yohe WB, Maurer SC (1979) Stimulation of Ca2+-dependent neurotransmitter release and presynaptic nerve terminal protein phosphorylation by calmodulin and a calmodulin-like protein isolated from synaptic vesicles. Proc Natl Acad Sci USA 76:1838–1842Google Scholar
- Douglas WW, Nemeth EF (1982) On the calcium receptor activating exocytosis: inhibitory effects of calmodulin-interacting drugs on rat mast cells. J Physiol 323:229–244Google Scholar
- Erulkar SD, Rahamimoff R (1978) The role of calcium ions in tetanic and post-tetanic increase of miniature end-plate potential frequency. J Physiol 278:501–511Google Scholar
- Erulkar SD, Rahamimoff R, Rotshenker S (1978) Quelling of spontaneous transmitter release by nerve impulses in low extracellular calcium solutions. J Physiol 278:491–500Google Scholar
- Heisler S, Chauvelot L, Desjardins D, Noel C, Lambert H, Desy-Audet L (1981) Stimulus-secretion coupling in exocrine pancreas: possible role of calmodulin. Can J Physiol Pharmacol 59:994–1001Google Scholar
- Hinds TF, Raess BU, Vincenzi FF (1981) Plasma membrane Ca2+ transport: antagonism by several potential inhibitors. J Membr Biol 58:57–65Google Scholar
- Kita H, Narita K, Van der Kloot W (1982) The relation between tonicity and impulse-evoked transmitter release in the frog. J Physiol 325: 213–222Google Scholar
- Landry Y, Amellal M, Ruckstuhl M (1981) Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol 30:2031–2032Google Scholar
- Lev-Tov A, Rahamimoff R (1980) A study of tetanic and post-tetanic potentiation of miniature end-plate potentials at the frog neuromuscular junction. J Physiol 309:247–273Google Scholar
- Means AR, Tash JS, Chafouleas JG (1982) Physiological implications of the presence, distribution and regulation of calmodulin in eukaryotic cells. Physiol Rev 62:1–39Google Scholar
- Naccache PH, Molski TFP, Alobaidi T, Becker EL, Showell MJ, Sha'afi RI (1980) Calmodulin inhibitors block neutrophil degranulation at a step distal from the mobilization of calcium. Biochem Biophys Res Commun 97:62–68Google Scholar
- Publicover SJ, Duncan CJ (1980) Stimulation of the frequency of MEPPs at the frog muscular junction by extracellular EGTA. Naunyn-Schmiedeberg's Arch Pharmacol 315:29–35Google Scholar
- Schubart UK, Erlichman J, Fleischer N (1980a) The role of calmodulin and the regulation of protein phosphorylation and insulin release in hamster insulinoma cells. J Biol Chem 255:4120–4124Google Scholar
- Schubart UK, Fleischer N, Erlichman J (1980b) Ca2+-dependent protein phosphorylation and insulin release in intact hamster insulinoma cells. Inhibition by trifluoperazine. J Biol Chem 255:11063–11066Google Scholar
- Statham HE, Duncan CJ (1975) The action of ionophores at the frog neuromuscular junction. Life Sci 17:1401–1406Google Scholar
- Valverde I, Sener A, Lebrun P, Herchuelz A, Malaisse WJ (1981) The stimulus-secretion coupling of glucose-induced insulin release. XLVII. The possible role of calmodulin. Endocrinology 108:1305–1312Google Scholar
- White CG, Raynor ST (1980) The effects of trifluoperazine, an inhibitor of calmodulin, on platelet function. Thromb Res 18:279–284Google Scholar